(Q36272985)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Anti-angiogenic therapy in pediatric neuro-oncology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

angiogenesis inhibitor

1 reference

1

Mark W Kieran

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

13 August 2017

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

327-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16195797%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-005-6764-6

7 January 2020

exact match

0 references

cites work

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-6764-6

Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

21 January 2018

1 reference

12 December 2020

Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

1 reference

12 December 2020

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

1 reference

12 December 2020

Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).

1 reference

12 December 2020

Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

1 reference

12 December 2020

Response of recurrent medulloblastoma to low-dose oral etoposide

1 reference

12 December 2020

Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor

1 reference

12 December 2020

High microvessel density in primitive neuroectodermal brain tumors of childhood.

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

1 reference

12 December 2020

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide

1 reference

12 December 2020

Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme

1 reference

12 December 2020

Effectiveness of Interferon-β, ACNU, and Radiation Therapy in Pediatric Patients with Brainstem Glioma

1 reference

12 December 2020

Non-cytotoxic therapies for malignant gliomas

1 reference

12 December 2020

Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models

1 reference

12 December 2020

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

1 reference

12 December 2020

Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling

1 reference

12 December 2020

Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders.

1 reference

12 December 2020

Thalidomide is an inhibitor of angiogenesis

1 reference

12 December 2020

Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas

1 reference

12 December 2020

Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling

1 reference

12 December 2020

Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.

1 reference

12 December 2020

Pediatric Tumor Cells Express Erythropoietin and a Functional Erythropoietin Receptor that Promotes Angiogenesis and Tumor Cell Survival

1 reference

12 December 2020

Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.

1 reference

12 December 2020

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

12 December 2020

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts

1 reference

12 December 2020

Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.

1 reference

12 December 2020

Surrogate markers in antiangiogenesis clinical trials

1 reference

12 December 2020

Inhibition of angiogenesis by non-toxic doses of temozolomide

1 reference

12 December 2020

Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.

1 reference

12 December 2020

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.

1 reference

12 December 2020

VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain

1 reference

12 December 2020

Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.

1 reference

12 December 2020

Chronic oral VP-16 for recurrent medulloblastoma

1 reference

12 December 2020

Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.

1 reference

12 December 2020

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

1 reference

12 December 2020

Local anti-angiogenic brain tumor therapies

1 reference

12 December 2020

Current and future strategies for the treatment of malignant brain tumors.

1 reference

12 December 2020

Therapeutic anti-angiogenesis for malignant brain tumors

1 reference

12 December 2020

Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells

1 reference

12 December 2020

Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.

1 reference

12 December 2020

Elevated plasma basic fibroblast growth factor in brain tumor patients.

1 reference

12 December 2020

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

1 reference

12 December 2020

Thrombospondins 1 and 2 function as inhibitors of angiogenesis

1 reference

12 December 2020

Expression of platelet-derived growth factor transcripts in medulloblastomas and ependymomas.

1 reference

12 December 2020

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

12 December 2020

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

1 reference

12 December 2020

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

12 December 2020

Anti-angiogenic agents for the treatment of brain tumors

1 reference

12 December 2020

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.

1 reference

12 December 2020

Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update

1 reference

12 December 2020

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations

1 reference

12 December 2020

Interferon alpha-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: a case report.

1 reference

12 December 2020

Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors.

1 reference

12 December 2020

Progress report on the potential of angiogenesis inhibitors for neuro-oncology

1 reference

12 December 2020

Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas

1 reference

12 December 2020

Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib

1 reference

12 December 2020

Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors.

1 reference

12 December 2020

Antiangiogenic therapy for primary and metastatic brain tumors

1 reference

12 December 2020

Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome.

1 reference

12 December 2020

Target molecules for anti-angiogenic therapy: from basic research to clinical trials

1 reference

12 December 2020

Positron emission tomographic imaging of angiogenesis and vascular function.

1 reference

12 December 2020

Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme

1 reference

12 December 2020

1 reference

12 December 2020

Antiangiogenic strategies and agents in clinical trials

1 reference

12 December 2020

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

1 reference

12 December 2020

Angiogenic factors in the central nervous system

1 reference

12 December 2020

Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis

1 reference

12 December 2020

Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction

1 reference

12 December 2020

The anti-angiogenic basis of metronomic chemotherapy

1 reference

12 December 2020

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas

1 reference

12 December 2020

Characteristic gene expression profile of primary human cerebral endothelial cells.

1 reference

12 December 2020

Stromal angiogenesis in human glioma: a role of platelet-derived endothelial cell growth factor.

1 reference

12 December 2020

Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme

1 reference

12 December 2020

Anti-angiogenic treatment strategies for malignant brain tumors

1 reference

12 December 2020

Antiangiogenesis therapy. Current and future agents

1 reference

12 December 2020

A preliminary study of angiogenesis in paediatric glioblastoma multiforme and its correlation with survival.

1 reference

12 December 2020

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

1 reference

12 December 2020

Tumor progression: the effects of thrombospondin-1 and -2.

1 reference

12 December 2020

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma.

1 reference

12 December 2020

Vascular development: molecular logic for defining arteries and veins

1 reference

12 December 2020

Innovative therapies for pediatric brain tumors

1 reference

12 December 2020

Thalidomide as an anti-angiogenic agent in relapsed gliomas

1 reference

12 December 2020

Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

1 reference

12 December 2020

Microvessel density in brain tumors.

1 reference

12 December 2020